ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,631
Screening encounters
2,928
Diagnostic referrals
572
Outstanding pathways
226

Screening pathway

  1. Screening2,928Encounters
  2. Positive finding1,003Documented findings
  3. Referral572Diagnostic referrals
  4. Follow-up649Diagnostic visits
  5. Outcome346Resolved pathways

Stage totals use different units. Pending pathways: 226. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0071 · EXP-0071Synthetic · Site C

Full participant history through 2026-04-16, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-02-01
  4. · Diagnostic referral · EXP-0071-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-09-26
  11. · Follow-up disposition · Resolved · EXP-0071-T-R
  12. · Screening · HPV DNA · Repeat · Prior VIA positive

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2631 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0484 · Expanded synthetic participant 0484Site A — Urban Referral Hub
EXP-0485 · Expanded synthetic participant 0485Site A — Urban Referral Hub
EXP-0487 · Expanded synthetic participant 0487Site E — Resource-Constrained Navigation Programme
EXP-0489 · Expanded synthetic participant 0489Site A — Urban Referral Hub
EXP-0491 · Expanded synthetic participant 0491Site D — Community Engagement Programme
EXP-0493 · Expanded synthetic participant 0493Site A — Urban Referral Hub
EXP-0496 · Expanded synthetic participant 0496Site B — Peri-Urban Access Programme
EXP-0497 · Expanded synthetic participant 0497Site D — Community Engagement Programme
EXP-0498 · Expanded synthetic participant 0498Site E — Resource-Constrained Navigation Programme
EXP-0499 · Expanded synthetic participant 0499Site A — Urban Referral Hub
EXP-0500 · Expanded synthetic participant 0500Site A — Urban Referral Hub
EXP-0501 · Expanded synthetic participant 0501Site A — Urban Referral Hub
EXP-0502 · Expanded synthetic participant 0502Site D — Community Engagement Programme
EXP-0503 · Expanded synthetic participant 0503Site C — Rural Outreach Programme
EXP-0508 · Expanded synthetic participant 0508Site B — Peri-Urban Access Programme
EXP-0509 · Expanded synthetic participant 0509Site B — Peri-Urban Access Programme
EXP-0510 · Expanded synthetic participant 0510Site D — Community Engagement Programme
EXP-0511 · Expanded synthetic participant 0511Site D — Community Engagement Programme
EXP-0518 · Expanded synthetic participant 0518Site A — Urban Referral Hub
EXP-0524 · Expanded synthetic participant 0524Site A — Urban Referral Hub
EXP-0528 · Expanded synthetic participant 0528Site D — Community Engagement Programme
EXP-0529 · Expanded synthetic participant 0529Site C — Rural Outreach Programme
EXP-0531 · Expanded synthetic participant 0531Site D — Community Engagement Programme
EXP-0532 · Expanded synthetic participant 0532Site D — Community Engagement Programme
EXP-0534 · Expanded synthetic participant 0534Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1203
HPV DNA
1289
Cytology
436

Navigation activity

Barrier documented
481
Contact attempt
836
Navigation intervention
207
Diagnostic booking
705
Diagnostic visit
649

Documented barriers

Contact difficulty
156
Transport difficulty
149
Appointment coordination
176

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.